Lataa...
Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism
Cardiovascular disease (CVD) is a major cause of morbidity and mortality worldwide. Inflammatory processes arising from metabolic abnormalities are known to precipitate the development of CVD. Several metabolic and inflammatory markers have been proposed for predicting the progression of CVD, includ...
Tallennettuna:
| Julkaisussa: | Br J Pharmacol |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5660004/ https://ncbi.nlm.nih.gov/pubmed/28326542 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13743 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|